 |
71 Diseases |  |
24 Trials |
|
24 Trials |  |
151 News |  |
| «1234 |
- | Trial completion: Action to Control Cardiovascular Risk in Diabetes (ACCORD) (clinicaltrials.gov) - Feb 6, 2014
P3, N=10251, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting --> Completed
- Novolin R (recombinant human insulin) / Novo Nordisk
New P2 trial: Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia (clinicaltrials.gov) - Jan 2, 2014
P2, N=8, Not yet recruiting, Sponsor: Medical University of Graz
- Lantus (insulin glargine) / Sanofi
Clinical: Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control (clinicaltrials.gov) - Sep 29, 2013
P=N/A, N=60, Completed, Sponsor: Taipei Veterans General Hospital, Taiwan
Active, not recruiting --> Completed Recruiting --> Completed
- Novolin R (recombinant human insulin) / Novo Nordisk
Trial completion: Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes (clinicaltrials.gov) - Jul 29, 2013
P2, N=64, Completed, Sponsor: Beth Israel Deaconess Medical Center
Recruiting --> Completed Recruiting --> Completed
- metformin / Generic mfg.
Enrollment change: MIPOD: Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes (clinicaltrials.gov) - May 21, 2013
P2, N=32, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Completed N=100 --> 32
- metformin / Generic mfg.
Trial completion: MIPOD: Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes (clinicaltrials.gov) - May 21, 2013
P2, N=32, Completed, Sponsor: University of North Carolina, Chapel Hill
N=100 --> 32 Recruiting --> Completed
- Novolin R (recombinant human insulin) / Novo Nordisk, Novolin N (isophane insulin) / Novo Nordisk
Clinical: Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=3, Recruiting, Sponsor: First Affiliated Hospital, Sun Yat-Sen University
- Novolin R (recombinant human insulin) / Novo Nordisk
Trial completion: Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline (clinicaltrials.gov) - Feb 14, 2013
P1, N=10, Completed, Sponsor: University of Turku
Recruiting --> Completed Recruiting --> Completed
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment closed: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) (clinicaltrials.gov) - Dec 16, 2012
P2, N=90, Active, not recruiting, Sponsor: University of Washington
Recruiting --> Completed Recruiting --> Active, not recruiting
- Novolin R (recombinant human insulin) / Novo Nordisk
Enrollment open: The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism (clinicaltrials.gov) - Nov 5, 2012
P=N/A, N=30, Recruiting, Sponsor: University of Aarhus
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | New P4 trial: Comparative randomized clinical trial between insulin analogues and human insulin in hospitalized patients treated with artificial tube feeding and who present high blood glucose levels. INSULINE study. Ensayo cl (EUDRACT) - Oct 21, 2012
P4, N=100, Ongoing, Sponsor: Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge.
- Enrollment open, Post-transplantation: PTHG: Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia (clinicaltrials.gov) - Oct 16, 2012
P4, N=120, Recruiting, Sponsor: Vancouver General Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||| Trial completion: Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) (clinicaltrials.gov) - Oct 3, 2012
P4, N=375, Completed, Sponsor: Guillermo Umpierrez
Not yet recruiting --> Recruiting Recruiting --> Completed
- Novolin R (recombinant human insulin) / Novo Nordisk
Trial completion: The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 Diabetes (clinicaltrials.gov) - Sep 16, 2012
P=N/A, N=18, Completed, Sponsor: University of Aarhus
Recruiting --> Completed Enrolling by invitation --> Completed
- | New P4 trial, Post-transplantation: PTHG: Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia (clinicaltrials.gov) - Jul 22, 2012
P4, N=120, Recruiting, Sponsor: Vancouver General Hospital
- | Novolin R (recombinant human insulin) / Novo Nordisk
Trial completion: Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis (clinicaltrials.gov) - Jul 5, 2012
P3, N=73, Completed, Sponsor: Mukoviszidose Institut gGmbH
Enrolling by invitation --> Completed Active, not recruiting --> Completed
- Novolin R (recombinant human insulin) / Novo Nordisk
Trial suspension: Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome (clinicaltrials.gov) - Jun 16, 2012
P4, N=130, Suspended, Sponsor: Universidade Positivo
Active, not recruiting --> Completed Recruiting --> Suspended
- Novolin R (recombinant human insulin) / Novo Nordisk
Trial initiation date: Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome (clinicaltrials.gov) - Jun 16, 2012
P4, N=130, Suspended, Sponsor: Universidade Positivo
Recruiting --> Suspended Initiation date: Jan 2010 --> Aug 2012
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P2 trial: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) (clinicaltrials.gov) - May 8, 2012
P2, N=90, Active, not recruiting, Sponsor: University of Washington
- | Novolin R (recombinant human insulin) / Novo Nordisk
New P1 trial: Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers (clinicaltrials.gov) - Oct 4, 2011
P1, N=28, Completed, Sponsor: Novo Nordisk
- Novolin R (recombinant human insulin) / Novo Nordisk
New P1 trial: Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline (clinicaltrials.gov) - Sep 14, 2011
P1, N=10, Completed, Sponsor: University of Turku
- Novolin R (recombinant human insulin) / Novo Nordisk
New P4 trial: Study of a Model-based Approach to Blood Glucose Control in Very-low-birthweight Neonates (clinicaltrials.gov) - Aug 11, 2011
P4, N=30, Completed, Sponsor: Christchurch Women's Hospital
- | Novolin R (recombinant human insulin) / Novo Nordisk
New P4 trial: Beneficios del tratamiento intensivo con insulina de las subidas de az (EUDRACT) - Aug 8, 2011
P4, N=204, Ongoing, Sponsor: Fundacio Sant Joan de Deu